Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

NCT ID: NCT01552174

Last Updated: 2015-09-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

185 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palpebral Pathologies Ocular Surface Disease Meibomian Gland Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Outpatients attending general ophthalmologic consultation

* Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
* Patients informed of the objectives of the survey and agreeing to participate.
* Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
* Patients informed of the objectives of the survey and agreeing to participate.
* Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iris Pharma

INDUSTRY

Sponsor Role collaborator

Axial Biotech, Inc

INDUSTRY

Sponsor Role collaborator

Laboratoires Thea

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

José Manuel Benitez del Castillo, Professor

Role: PRINCIPAL_INVESTIGATOR

USIO, Departamento de Oftalmología, Hospital Clínico San Carlos, 28040 Madrid, Spain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Consultation office

Heidelberg, , Germany

Site Status

USIO Departamento de Oftalmologia Hospital Clínico San Carlos

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MEIBUM survey

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treating Lid Wiper Epitheliopathy
NCT06671041 COMPLETED PHASE4